D. E. Shaw & Co., Inc. Forte Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $22,771 - $32,987	-21,282 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.21 - $2.24 $25,751 - $47,671	21,282 New	21,282 $31,000
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $129,502 - $1.6 Million	-43,751 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $592,231 - $799,042	18,801 Added 75.35%	43,751 $1.47 Million
Q1 2021 May 17, 2021	BUY	$25.01 - $40.24 $623,999 - $1 Million	24,950 New	24,950 $855,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.